Jabs graduated valedictorian from Dartmouth College in 1973 with a degree in chemistry. He received his medical degree from Johns Hopkins School of Medicine in 1977. He completed an internship in internal medicine at New York Hospital–Cornell Medical Center, a residency in internal medicine at The Johns Hopkins Hospital and a residency in ophthalmology at the Wilmer Eye Institute, and a rheumatology fellowship at Johns Hopkins.
Jabs joined the faculty at the Johns Hopkins School of Medicine in 1984 as Assistant Professor. He was named Associate Professor of Ophthalmology in 1988, and Associate Professor of Medicine in 1989. In 1993 he was named Professor of both Ophthalmology and Medicine, and in 2000 he was named Professor of Epidemiology at the Bloomberg School of Public Health. In 2007, he was named Professor and Chair of the Department of Ophthalmology at The Mount Sinai Medical Center. In 2009, he was chosen as the Chief Executive Officer of the Mount Sinai Faculty Practice Associates and Dean for Clinical Affairs of the Mount Sinai School of Medicine.
Jabs currently chairs both the Study of Ocular Complications of AIDS (SOCA) Research Group and the Multicenter Uveitis Steroid Treatment (MUST) Trial. He has chaired five randomized, controlled, clinical trials on the treatment of CMV retinitis and now chairs a multicenter epidemiologic study investigating the long–term outcomes of patients with ocular complications of AIDS, particularly CMV retinitis. Jabs has been instrumental in leading the Standardization of Uveitis (SUN) project, an effort to standardize terminology and outcomes related to uveitis. He has served on numerous data and safety monitoring committees for clinical trials, both those sponsored by the National Institutes of Health and the pharmaceutical industry.
Affiliations
*1980 – American Association for the Advancement of Science*1981 – Association for Research in Vision and Ophthalmology
*1982 – Fellow, American Academy of Ophthalmology
*1985 – American Uveitis Society
*1985 – Ocular Microbiology and Immunology Group
*1985 – Fellow, American College of Rheumatology
*1990 – The Macula Society
*1995 – American Ophthalmological Society
*1998 – International Uveitis Study Group
*2000 – Society for Clinical Trials
*2001 – The Retina Society
*2001 – American Society of Retina Specialist
*2008 – New York Ophthalmologic Society
*2008 – Manhattan Ophthalmologic Society
*2009 – Ophthalmic Laser Surgery Society, New York
Editorial appointments
*1989–present – Retina – The Journal of Retinal and Vitreous Diseases, Editorial Board*1999–present – Ocular Immunology and Inflammation, Editorial Board
*2002–present – American Journal of Ophthalmology, Editorial Board
*2002-2007 – American Journal of Ophthalmology, Executive Editor
*2008-2009 – Ophthalmic Epidemiology, Editorial Board
Additionally, Jabs is a reviewer for the American Journal of Ophthalmology, Annals of Internal Medicine, Archives of Ophthalmology, Current Eye Research, Investigative Ophthalmology & Visual Science, Journal of American Medical Association, Journal of Immunology, Journal of Infectious Disease, Medicine, New England Journal of Medicine, Ophthalmic Epidemiology, Ophthalmology, Retina, and Survey of Ophthalmology.
Awards and honors
*1986-1987 – Johns Hopkins University Clinician Scientist Award*1991 – Research to Prevent Blindness Olga Keith Weiss Scholar Award
*1997 – Research to Prevent Blindness Lew R. Wasserman Merit Award
*2002 – Research to Prevent Blindness Senior Scientific Investigator
*2005 – American Academy of Ophthalmology Senior Achievement Award
*2007 – Clinical Uveitis Research Award from the German Uveitis Patient Interest Group
*2008 – EyeCare America, Lifetime Volunteer Physician Award
*2009 – European Uveitis Patient Interest Association (EUPIA) Uveitis Award
Adapted from the Wikipedia article Douglas Jabs, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki
